Eudaimonia Advisors’s Medtronic MDT Stock Holding History

Eudaimonia Advisors’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,266	Closed	-$234K	–	175
2021 Q4	$234K	Buy	+2,266	New	+$262K	0.14%	151

Other funds holding MDT

WestEnd Advisors Charlotte, North Carolina $4.14B AUM 15.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Eudaimonia Advisors's MDT Position: Q1 2022 in Review

Eudaimonia Advisors sold out of Medtronic (MDT) in Q1 2022, closing a stake of 2,266 shares — an estimated $234K sold.

Eudaimonia Advisors first reported a position in MDT in Q4 2021 and held it in 1 quarter. The position peaked at $234K in Q4 2021. 2,101 funds tracked by Wall St. Rank hold MDT as of Q1 2022.

Eudaimonia Advisors reported no remaining Medtronic position as of Q1 2022 after selling out during the quarter.
Eudaimonia Advisors sold 2,266 Medtronic shares in Q1 2022, an estimated $234K.
Eudaimonia Advisors first reported a position in Medtronic in Q4 2021 and held it in 1 quarter.
Eudaimonia Advisors's Medtronic position peaked at $234K in Q4 2021.
2,101 funds tracked by Wall St. Rank held Medtronic as of Q1 2022.

Based on Eudaimonia Advisors's 13F filing for Q1 2022, filed 16 May 2022.